[1. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours. 2002, Lyon, France: IARC Press, 9-175.]Search in Google Scholar
[2. Beaman F, Jelinek J, Priebat D. Current imaging and therapy of malignant soft tissue tumors and tumor-like lesions. Semin Musculoskelet Radiol. 2013; 17(02):168-176.10.1055/s-0033-134309423673548]Search in Google Scholar
[3. Soft tissue sarcoma statistics. Cancer Research UK. http://www.cancerresearchuk.org/healthprofessional/cancer-statistics/statistics-bycancertype/soft-tissue-sarcoma#heading-Zero.]Search in Google Scholar
[4. Jemal A, Tiwari RC, Murray T et al. Cancer statistics 2004. CA Cancer J Clin. 2004; 54:8-29.10.3322/canjclin.54.1.814974761]Open DOISearch in Google Scholar
[5. Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000; 151(1):33-40.10.1093/oxfordjournals.aje.a01011810625171]Search in Google Scholar
[6. Chen CS, Suthers G, Carroll J, Rudzki Z, Muecke J. Sarcoma and familial retinoblastoma. Clin Exp Ophthal. 2003; 31(5):392-6.10.1046/j.1442-9071.2003.00684.x14516425]Search in Google Scholar
[7. Bell DW, Varley JM, Szydlo TE, Kanf DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 1999; 286(5449):2528-31.10.1126/science.286.5449.252810617473]Search in Google Scholar
[8. http://www.lifemath.net/cancer/sarcoma/outcome/index.php.]Search in Google Scholar
[9. Fletcher CDM, Bridge JA, Hogendoom P, Mertens F. WHO Classification of soft tissue tumors, Volume 5: WHO Classification of Soft Tissue and Bone, 4th ed., 2013, Geneva: WHO Press.]Search in Google Scholar
[10. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinico histopathologic correlation in a series of 163 cases.]Search in Google Scholar
[11. Enneking WF. Staging of musculoskeletal tumors. In: Enneking WF. Musculoskeletal Tumor Surgery, vol. 1, 1983, New York: Churchill Livingstone, 87-8.10.1007/978-3-642-69210-9_1]Search in Google Scholar
[12. http://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging.aspx.]Search in Google Scholar
[13. Knapp EL, Kransdorf MJ, Letson GD. Diagnostic imaging update: soft tissue sarcomas. Cancer Control. 2005; 12(1):22-26.10.1177/10732748050120010315668649]Search in Google Scholar
[14. Bancroft L, Pettis C, Wasyliw C. Imaging of benign soft tissue tumors. Semin Musculoskelet Radiol. 2013; 17(02):156-167.10.1055/s-0033-134307123673547]Search in Google Scholar
[15. Smith S, Salanitri J, Lisle D. Ultrasound evaluation of soft tissue masses and fluid collections. Semin Musculoskelet Radiol. 2007; 11(2):174-191.10.1055/s-2007-100188218095249]Search in Google Scholar
[16. Downes KA, Goldblum JR, Montgomery EA et al. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001; 14:179-184.10.1038/modpathol.388028011266523]Search in Google Scholar
[17. Kooby DA, Antonescu CR, Brennan MF et al. Atypical lipomatous tumor/ well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004; 11(1):78-84. 10.1007/BF02524350.10.1007/BF0252435014699038]Search in Google Scholar
[18. Rom J Morphol Embryol. 2015; 56(1):169-73.]Search in Google Scholar
[19. Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for patients with localized soft tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003; 97:2530-2543.10.1002/cncr.1136512733153]Search in Google Scholar
[20. Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol. 2003; 15(4):319-26.10.1097/00001622-200307000-0000712874511]Open DOISearch in Google Scholar